The experimental content is RIP-Seq (RNA co-immunoprecipitation combined with high-throughput sequencing)
However, despite the promising outlook, several challenges impede the mainstream adoption of plant-based GLP-1 agonists
#clinicalresearch #GLP1 #healthtech #obesity #virtualcare To view or add a comment, sign in BMI is a widely used screening tool, but it was never designed to tell the whole story
Physician Shift Toward Once-Weekly And Dual-Incretin Therapies Brazilian and Mexican endocrinologists report 30%-40% higher 12-month persistence for once-weekly semaglutide or dulaglutide compared with daily liraglutide
Meet our experts Gillian Goddard , MD, a board-certified endocrinologist, adjunct assistant professor of medicine at NYU Grossman School of Medicine and author of The Hormone Loop Edwin Davila , DO, internal medicine physician, scientific advisory board member at the National Academy of Sports Medicine Anath Shalev , MD, director of the University of Alabama at Birmingham Comprehensive Diabetes Center Thomas Rutledge , PhD, staff psychologist at the VA San Diego Healthcare System, professor of psychiatry at UC San Diego Our health content is for informational purposes only and is not intended as professional medical advice